Medicine

International Internet Magazine. Baltic States news & analytics Thursday, 11.02.2016, 16:56

1 ..2 ..3 ..4 ..5 ..6 ..7 ..8 ..9 ..10 ..11 [>][>>>]
Sales Latvian drug wholesalers grew by 2% in Q4

Sales Latvian drug wholesalers grew by 2% in Q4

05.02.2016

In the fourth quarter of 2015, Latvian drug wholesale companies raised their aggregate sales 2% year-on-year to EUR 117.28 million, in forms LETA, according to information from the State Agency of Medicines.

Keyword tags: Baltic Export, Good for Business, Latvia, Markets and Companies, Medicine



Less deaths caused by cancer in Estonia than on average in EU

Less deaths caused by cancer in Estonia than on average in EU

03.02.2016

In Estonia, the number of deaths caused by cancer is smaller than the European Union average and remarkably less people younger than 65 die of cancer in Estonia than in the EU, results of a study carried out by Eurostat show, cites LETA/BNS.

First corneal endothelial transplantation performed in Lithuania

First corneal endothelial transplantation performed in Lithuania

28.01.2016

The first transplantation of corneal endothelium, the inner layer of the cornea, has been performed at Kaunas Clinics in Lithuania, the hospital said on Thursday, informs LETA/BNS.


Linnamae brings Magnum under Up Invest in Estonia

Linnamae brings Magnum under Up Invest in Estonia

27.01.2016

Estonian businessman Margus Linnamae, who used to own the pharmaceuticals and hospital supplies seller Magnum AS directly via a company registered in the Netherlands, brought Magnum under his holding company Up Invest OU earlier in January 2016, informs LETA/BNS.

Biosan Latvia participated in the creation of a vaccine against Ebola

Biosan Latvia participated in the creation of a vaccine against Ebola

27.01.2016

The essence of the high-tech business of Biosan Latvia is related to biosafety which is one of the aspects that were raised in the TV program about the terrible epidemic of Ebola virus. In this area Biosan is Russia's reputable and reliable partner. BC asked for comments from the Chairman of the Board of Biosan, doctor of biology, professor Vasily Bankovsky.

26.01.2016

Estonian competence center sells cancer drug in development stage to US company

The Estonian Competence Center for Cancer Research (CCCR) and the Russian company Pharmsynthez have sold intellectual property rights with respect to Virexxa, a candidate for approval as endometrial cancer drug in the United States, to the U.S. biotechnology company Xenetic Biosciences, reports LETA/BNS.

25.01.2016

Latvia's Norde company to contest results of ambulance car tender at court

Latvia's Norde car dealer will turn to the Administrative Court to contest the decision of the Procurement Supervision Bureau (IUB) on results of the tender held by the Latvian Emergency Medical Aid Service (NMPD) to buy 52 ambulance cars.

1 ..2 ..3 ..4 ..5 ..6 ..7 ..8 ..9 ..10 ..11 [>][>>>]

Search site